Page last updated: 2024-10-25

chlorpropamide and Graves Disease

chlorpropamide has been researched along with Graves Disease in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LINQUETTE, M1
FOSSATI, P1
GASNAULT, JP1
RACADOT, A1

Other Studies

1 other study available for chlorpropamide and Graves Disease

ArticleYear
[THE INTRAVENOUS CHLORPROPAMIDE TEST. EARLY AND LATE RESPONSES].
    Le Diabete, 1964, Volume: 12

    Topics: Acromegaly; Blood Glucose; Chlorpropamide; Cushing Syndrome; Goiter; Graves Disease; Humans; Hypogly

1964